Sphera Funds Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Sphera Funds Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-260,000	Closed	-$7.74M	–	145
2018 Q1	$7.74M	Buy	260,000 +35,000	+16%	+$1.13M	1.18%	21
2017 Q4	$7.24M	Buy	225,000 +75,000	+50%	+$2.45M	0.85%	24
2017 Q3	$5.22M	Buy	150,000 +25,000	+20%	+$804K	0.74%	34
2017 Q2	$3.72M	Buy	125,000 +15,000	+14%	+$430K	0.63%	48
2017 Q1	$3.28M	Buy	110,000 +59,323	+117%	+$1.51M	0.64%	45
2016 Q4	$888K	Buy	+50,677	New	+$971K	0.22%	87
2015 Q1	–	Sell	-100,230	Closed	-$1.85M	–	189
2014 Q4	$1.85M	Sell	100,230 -123,100	-55%	-$1.46M	0.32%	93
2014 Q3	$2.15M	Buy	+223,330	New	+$2.22M	0.27%	80

Other funds holding LJPC

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Sphera Funds Management's LJPC Position: Q2 2018 in Review

Sphera Funds Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 260,000 shares — an estimated $7.74M sold.

Sphera Funds Management first reported a position in LJPC in Q3 2014 and held it in 8 quarters. The position peaked at $7.74M in Q1 2018. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

Sphera Funds Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
Sphera Funds Management sold 260,000 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $7.74M.
Sphera Funds Management first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 8 quarters.
Sphera Funds Management's La Jolla Pharmaceutical Company position peaked at $7.74M in Q1 2018.
95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on Sphera Funds Management's 13F filing for Q2 2018, filed 13 Aug 2018.